The role for ketogenic diets in epilepsy and status epilepticus in adults

Tanya J Williams, Mackenzie C Cervenka, Tanya J Williams, Mackenzie C Cervenka

Abstract

Ketogenic diet (KD) therapies are high fat, low carbohydrate diets designed to mimic a fasting state. Although studies demonstrate KD's success in reducing seizures stretching back nearly a century, the last 25 years have seen a resurgence in diet therapy for the management of drug-resistant epilepsy in children as well as adults. With ≥50% seizure reduction efficacy rates in adults of 22-55% for the classic KD and 12-67% for the modified Atkins diet, diet therapy may be in many instances comparable to a trial of an additional anti-epileptic medication and potentially with fewer side effects and other health benefits. Moreover, ketogenic diets offer promising new adjunctive strategies for the treatment of acute status epilepticus in the intensive care setting. Here, we review the efficacy and utility of ketogenic diets for the management of chronic epilepsy and refractory status epilepticus in adults and offer practical guidelines for diet implementation and maintenance.

Keywords: Drug-resistant epilepsy; Epilepsy; Ketogenic diet; Modified Atkins diet; Refractory status epilepticus.

References

    1. Amer S., Shah P., Kommineni V. Refractory status epilepticus from NMDA receptor encephalitis successfully treated with an adjunctive ketogenic diet. Ann. Indian Acad. Neurol. 2015;18:256–257.
    1. Barañano K.W., Hartman A.L. The ketogenic diet: uses in epilepsy and other neurologic illnesses. Curr. Treat. Options Neurol. 2008;10:410–419.
    1. Barborka C.J. Ketogenic diet treatment of epilepsy in adults. JAMA. 1928;9:73–78.
    1. Barborka C.J. Epilepsy in adults: results of treatment by ketogenic diet in one hundred cases. Arch. Neurol. Psychiatr. 1930;23:904–914.
    1. Bastible C. The ketogenic treatment of epilepsy. Irish J. Med. Sci. 1931;6:506–520.
    1. Baumeister F.A.M., Oberhoffer R., Liebhaber G.M., Kunkel J., Eberhardt J., Holthausen H., Peters J. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics. 2004;35:250–252.
    1. Bergin A.M. Ketogenic diet in established epilepsy indications. In: Masino S.A., editor. Ketogenic Diet and Metabolic Therapies: Expanded Roles in Health and Disease. Oxford University Press; New York: 2017. pp. 40–49.
    1. Bergqvist A.G.C., Schall J.I., Stallings V.A., Zemel B.S. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am. J. Clin. Nutr. 2008;88:1678–1684.
    1. The Bible. Mark 9:14-29, New King, J. (Ed.), 1982. Guideposts, Carmel, NY.
    1. Bodenant M., Moreau C., Sejourné C., Auvin S., Delval A., Cuisset J.-M., Derambure P., Destée A., Defebvre L. Interest of the ketogenic diet in a refractory status epilepticus in adults. Rev. Neurol. (Paris) 2008;164:194–199.
    1. Brodie M.J., Barry S.J.E., Bamagous G.A., Norrie J.D., Kwan P. Patterns of treatment response in newly diagnosed epilepsy. Neurology. 2012;78:1548–1554.
    1. Carrette E., Vonck K., de Herdt V., Dewaele I., Raedt R., Goossens L., Van Zandijcke M., Wadman W., Thadani V., Boon P. A pilot trial with modified Atkins’ diet in adult patients with refractory epilepsy. Clin. Neurol. Neurosurg. 2008;110:797–803.
    1. Cervenka M.C., Kossoff E.H. Dietary treatment of intractable epilepsy. Continuum (Minneap. Minn) 2013;19:756–766.
    1. Cervenka M.C., Terao N.N., Bosarge J.L., Henry B.J., Klees A.A., Morrison P.F., Kossoff E.H. E-mail management of the modified Atkins diet for adults with epilepsy is feasible and effective. Epilepsia. 2012;53:728–732.
    1. Cervenka M.C., Henry B.J., Felton E.A., Patton K., Kossoff E.H. Establishing an adult epilepsy diet center: experience, efficacy and challenges. Epilepsy Behav. 2016;58:61–68.
    1. Cervenka M.C., Patton K., Eloyan A., Henry B., Kossoff E.H. The impact of the modified Atkins diet on lipid profiles in adults with epilepsy. Nutr. Neurosci. 2016;19:131–137.
    1. Cervenka M.C., Henry-Barron B.J., Kossoff E.H. Is there a role for diet monotherapy in adult epilepsy? Epilepsy Behav. Case Rep. 2017;7:6–9.
    1. Cervenka M.C., Hocker S.E., Koenig M., Bar B., Henry-Barron B., Kossoff E.H., Hartman A.L., Probasco J.C., Benavides D.R., Venkatesan A., Hagen E.C., Dittrich D., Stern T., Radzik B., Depew M., Caserta F.M., Nyquist P., Kaplan P.W., Geocadin R.G. A phase I/II multicenter ketogenic diet study for adult super-refractory status epilepticus. Neurology. 2017;88:938–943.
    1. Coppola G., D’Aniello A., Messana T., Di Pasquale F., Della Corte R., Pascotto A., Verrotti A. Low glycemic index diet in children and young adults with refractory epilepsy: first Italian experience. Seizure. 2011;20:526–528.
    1. De Vivo D.C., Trifiletti R.R., Jacobson R.I., Ronen G.M., Behmand R.A., Harik S.I. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. NEJM. 1991;325:703–709.
    1. Furth S.L., Casey J.C., Pyzik P.L., Neu A.M., Docimo S.G., Vining E.P., Freeman J.M., Fivush B.A. Risk factors for urolithiasis in children on the ketogenic diet. Pediatr. Nephrol. 2000;15:125–128.
    1. Hippocrates., 400BC. On the Sacred Disease. (accessed 5.16.17).
    1. Hocker S.E., Britton J.W., Mandrekar J.N., Wijdicks E.F.M., Rabinstein A.A. Predictors of outcome in refractory status epilepticus. JAMA Neurol. 2013;70:72–77.
    1. Johnson E.L., Cervenka M.C. Dietary therapy in adults: history, demand, and results. In: Masino S.A., editor. Ketogenic Diet and Metabolic Therapies: Expanded Roles in Health and Disease. Oxford University Press; New York: 2017. pp. 16–25.
    1. Kass H.R., Winesett S.P., Bessone S.K., Turner Z., Kossoff E.H. Use of dietary therapies amongst patients with GLUT1 deficiency syndrome. Seizure. 2016;35:83–87.
    1. Klein P., Janousek J., Barber A., Weissberger R. Ketogenic diet treatment in adults with refractory epilepsy. Epilepsy Behav. 2010;19:575–579.
    1. Klein P., Tyrlikova I., Mathews G.C. Dietary treatment in adults with refractory epilepsy: a review. Neurology. 2014;83:1978–1985.
    1. Klepper J., Leiendecker B. GLUT1 deficiency syndrome–2007 update. Dev. Med. Child Neurol. 2007;49:707–716.
    1. Kossoff E.H., Pyzik P.L., Furth S.L., Hladky H.D., Freeman J.M., Vining E.P.G. Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet. Epilepsia. 2002;43:1168–1171.
    1. Kossoff E.H., Krauss G.L., Mcgrogan J.R., Freeman J.M. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology. 2003;61:1789–1792.
    1. Kossoff E.H., Rowley H., Sinha S.R., Vining E.P.G. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia. 2008;49:316–319.
    1. Kossoff E.H., Zupec-Kania B.A., Amark P.E., Ballaban-Gil K.R., Christina Bergqvist A.G., Blackford R., Buchhalter J.R., Caraballo R.H., Helen Cross J., Dahlin M.G., Donner E.J., Klepper J., Jehle R.S., Kim H.D., Christiana Liu Y.M., Nation J., Nordli D.R., Pfeifer H.H., Rho J.M., Stafstrom C.E., Thiele E.A., Turner Z., Wirrell E.C., Wheless J.W., Veggiotti P., Vining E.P.G., Anderson A., Cohen B., Currey M., Donley D., Dure L., Garg B., Goldstein M., Grabert B., Griesemer D., Kovnar E., Larson R., Legido A., Morrison L.A., Parker C., Renfroe J.Ben., Schreck J., Shinnar S., Snyder R., Tardo C., Timmons G.D., Yim G. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2009;50:304–317.
    1. Kossoff E.H., Henry B.J., Cervenka M.C. Transitioning pediatric patients receiving ketogenic diets for epilepsy into adulthood. Seizure. 2013;22:487–489.
    1. Kossoff E.H., Cervenka M.C., Henry B.J., Haney C.A., Turner Z. A decade of the modified Atkins diet (2003–2013): results, insights, and future directions. Epilepsy Behav. 2013;29:437–442.
    1. Kossoff E.H., Henry B.J., Cervenka M.C. Efficacy of dietary therapy for juvenile myoclonic epilepsy. Epilepsy Behav. 2013;26:162–164.
    1. Kossoff E.H., Veggiotti P., Genton P., Desguerre I. Transition for patients with epilepsy due to metabolic and mitochondrial disorders. Epilepsia. 2014;55:37–40.
    1. Kossoff E.H., Al-Macki N., Cervenka M.K.C., Kim H.D., Liao J., Megaw K., Nathan J.K., Raimann X., Rivera R., Wiemer-Kruel A., Williams E., Zupec-Kania B.A. What are the minimum requirements for ketogenic diet services in resource-limited regions? Recommendations from the International League Against Epilepsy Task Force for Dietary Therapy. Epilepsia. 2015;56:1337–1342.
    1. Kverneland M., Selmer K.K., Nakken K.O., Iversen P.O., Taubøll E. A prospective study of the modified Atkins diet for adults with idiopathic generalized epilepsy. Epilepsy Behav. 2015;53:197–201.
    1. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N. Engl. J. Med. 2000;342:314–319.
    1. Lambrechts D.A.J.E., Wielders L.H.P., Aldenkamp A.P., Kessels F.G.H., de Kinderen R.J.A., Majoie M.J.M. The ketogenic diet as a treatment option in adults with chronic refractory epilepsy: efficacy and tolerability in clinical practice. Epilepsy Behav. 2012;23:310–314.
    1. Lee P.R., Kossoff E.H. Dietary treatments for epilepsy: management guidelines for the general practitioner. Epilepsy Behav. 2011;21:115–121.
    1. Maalouf M., Rho J.M., Mattson M.P. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res. Rev. 2009;59:293–315.
    1. Maalouf N.M., Langston J.P., Van Ness P.C., Moe O.W., Sakhaee K. Nephrolithiasis in topiramate users. Urol. Res. 2011;39:303–307.
    1. Mackay M.T., Bicknell-Royle J., Nation J., Humphrey M., Harvey A.S. The ketogenic diet in refractory childhood epilepsy. J. Paediatr. Child Health. 2005;41:353–357.
    1. Martikainen M.H., Paivarinta M., Jaaskelainen S., Majamaa K., Martikainen M.H., P.M. J.S. M.K. Successful treatment of POLG-related mitochondrial epilepsy. Epileptic Disord. 2012;14:438–441.
    1. Martin K., Jackson C.F., Levy R.G., Cooper P.N. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst. Rev. 2016;2016
    1. McNally M.A., Hartman A.L. Ketone bodies in epilepsy. J. Neurochem. 2012;121:28–35.
    1. Mosek A., Natour H., Neufeld M.Y., Shiff Y., Vaisman N. Ketogenic diet treatment in adults with refractory epilepsy: a prospective pilot study. Seizure. 2009;18:30–33.
    1. Moshé S.L., Perucca E., Ryvlin P., Tomson T. Epilepsy: new advances. Lancet. 2015;385:884–898.
    1. Muzykewicz D.A., Lyczkowski D.A., Memon N., Conant K.D., Pfeifer H.H., Thiele E.A. Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy. Epilepsia. 2009;50:1118–1126.
    1. Nam S.H., Lee B.L., Lee C.G., Yu H.J., Joo E.Y., Lee J., Lee M. The role of ketogenic diet in the treatment of refractory status epilepticus. Epilepsia. 2011;52:e181–e184.
    1. Nangia S., Caraballo R.H., Kang H.C., Nordli D.R., Scheffer I.E. Is the ketogenic diet effective in specific epilepsy syndromes? Epilepsy Res. 2012;100:252–257.
    1. Neal E.G., Cross J.H. Efficacy of dietary treatments for epilepsy. J. Hum. Nutr. Diet. 2010;23:113–119.
    1. Nei M., Ngo L., Sirven J.I., Sperling M.R. Ketogenic diet in adolescents and adults with epilepsy. Seizure. 2014;23:439–442.
    1. Paoli A., Rubini A., Volek J.S., Grimaldi K.A. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur. J. Clin. Nutr. 2013;67:789–796.
    1. Payne N.E., Cross J.H., Sander J.W., Sisodiya S.M. The ketogenic and related diets in adolescents and adults-a review. Epilepsia. 2011;52:1941–1948.
    1. Pfeifer H.H., Thiele E.A. Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology. 2005;65:1810–1812.
    1. Pong A.W., Geary B.R., Engelstad K.M., Natarajan A., Yang H., De Vivo D.C. Glucose transporter type i deficiency syndrome: epilepsy phenotypes and outcomes. Epilepsia. 2012;53:1503–1510.
    1. Ramm-Pettersen A., Nakken K.O., Skogseid I.M., Randby H., Skei E.B., Bindoff L.A., Selmer K.K. Good outcome in patients with early dietary treatment of GLUT-1 deficiency syndrome: results from a retrospective Norwegian study. Dev. Med. Child Neurol. 2013;55:440–447.
    1. Rubenstein J.E., Kossoff E.H., Pyzik P.L., Vining E.P.G., McGrogan J.R., Freeman J.M. Experience in the use of the ketogenic diet as early therapy. J. Child Neurol. 2005;20:31–34.
    1. Schoeler N.E., Cross J.H. Ketogenic dietary therapies in adults with epilepsy: a practical guide. Pr. Neurol. 2016;16:208–214.
    1. Schoeler N.E., Wood S., Aldridge V., Sander J.W., Cross J.H., Sisodiya S.M. Ketogenic dietary therapies for adults with epilepsy: feasibility and classification of response. Epilepsy Behav. 2014;37:77–81.
    1. Sharman M.J., Kraemer W.J., Love D.M., Avery N.G., Gómez A.L., Scheett T.P., Volek J.S. A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men. J. Nutr. 2002;132:1879–1885.
    1. Shorvon S., Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134:2802–2818.
    1. Shorvon S., Ferlisi M. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain. 2012;135:2314–2328.
    1. Sirven J., Whedon B., Caplan D., Liporace J., Glosser D., O’Dwyer J., Sperling M.R. The ketogenic diet for intractable epilepsy in adults: preliminary results. Epilepsia. 1999;40:1721–1726.
    1. Smith M., Politzer N., MacGarvie D., McAndrews M.P., Del Campo M. Efficacy and tolerability of the Modified Atkins Diet in adults with pharmacoresistant epilepsy: a prospective observational study. Epilepsia. 2011;52:775–780.
    1. Strzelczyk A., Reif P.S., Bauer S., Belke M., Oertel W.H., Knake S., Rosenow F. Intravenous initiation and maintenance of ketogenic diet: proof of concept in super-refractory status epilepticus. Seizure. 2013;22:581–583.
    1. Thakur K.T., Probasco J.C., Hocker S.E., Roehl K., Henry B., Kossoff E.H., Kaplan P.W., Geocadin R.G., Hartman A.L., Venkatesan A., Cervenka M.C. Ketogenic diet for adults in super-refractory status epilepticus. Neurology. 2014;82:665–670.
    1. Thibert R.L., Pfeifer H.H., Larson A.M., Raby A.R., Reynolds A.A., Morgan A.K., Thiele E.A. Low glycemic index treatment for seizures in Angelman syndrome. Epilepsia. 2012;53:1498–1502.
    1. Trauner D.A. Medium-chain triglyceride (MCT) diet in intractable seizure disorders. Neurology. 1985;35:237–238.
    1. van der Louw E.J., Williams T.J., Henry-Barron B.J., Olieman J.F., Duvekot J.J., Vermeulen M.J., Bannink N., Williams M., Neuteboom R.F., Kossoff E.H., Catsman-Berrevoets C.E., Cervenka M.C. Ketogenic diet therapy for epilepsy during pregnancy: a case series. Seizure. 2017;45:198–201.
    1. Wusthoff C.J., Kranick S.M., Morley J.F., Bergqvist A.G.C. The ketogenic diet in treatment of two adults with prolonged nonconvulsive status epilepticus. Epilepsia. 2010;51:1083–1085.
    1. Ye F., Li X.J., Jiang W.L., Sun H.Bin., Liu J. Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis. J. Clin. Neurol. 2015;11:26–31.
    1. Zengin A., Kropp B., Chevalier Y., Junnila R., Sustarsic E., Herbach N., Fanelli F., Mezzullo M., Milz S., Bidlingmaier M., Bielohuby M. Low-carbohydrate, high-fat diets have sex-specific effects on bone health in rats. Eur. J. Nutr. 2015;55:2307–2320.
    1. Zupec-Kania B.A., Spellman E. An overview of the ketogenic diet for pediatric epilepsy. Nutr. Clin. Pract. 1998;23:589–596.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner